Sridhar Ramaswamy, CEO of Snowflake and formerly co-founder and CEO of startup Neeva, speaks at the Collision conference in Toronto on June 21, 2022.
Eóin Noonan | Sportsfile | Collision | Getty Images
Shares of Snowflake fell 13% on Thursday after the data cloud analytics company released fiscal second-quarter 2025 earnings that beat Wall Street’s estimates but showed decelerating product revenue growth compared to past quarters.
Snowflake reported $869 million in revenue, above the $851 million expected by analysts polled by LSEG. The company reported $829.3 million in product revenue, which accounts for most of Snowflake’s sales, up 30% year over year. But that marked a slowdown from the 34% year-over-year bump reported during the fiscal first quarter.
The company’s net loss widened to $317 million, or a 95 cent loss per share, from $227 million, or a loss of 69 cents per share, during the same period a year earlier.
Morgan Stanley analysts said Snowflake’s results were good, “but perhaps not enough.” They said the company’s smaller product revenue beat and deceleration in growth will not inspire weary investors.
The analysts think Snowflake’s new generative artificial intelligence portfolio will eventually contribute to topline outperformance. In the meantime, it will have to rely on its core data warehousing business.
“A 2% product revenue beat in Q2, down from 5% in Q1, with product revenue growth dipping further to 29.5% YoY,” likely sows “enough doubt in the investor conversation to keep shares under pressure in the near-term,” the analysts wrote in a note Thursday.
Analysts at Barclays said Snowflake’s second-quarter results should “not be a major catalyst either way” for the company’s investment case. They maintained their equal weight rating on the stock.
The analysts said investors were watching closely to see whether the company’s product revenue took a material hit because of fallout from a cyberattack and the CrowdStrike outage that occurred during the quarter. They felt these potential large headwinds did not play out, which is a positive for the company.
“True, 30% y/y product growth is slower than the 33-34% level we saw the past 2 quarters. However, against all the fear going into these results we see the 30% level and raised guide as very respectable, especially given the lower valuation,” the analysts wrote in a note Wednesday.
— CNBC’s Michael Bloom contributed to this report.